NEXGEL, Inc.
Market Cap
$8.77M
P/E Ratio
-2.23
EPS
$-0.37
Dividend Yield
0.00%
52-Week Range
$0.70 — $3.25
Volume
108.52K
Avg Volume
254.60K
Beta
0.62
P/E (TTM)
-2.23
Forward P/E
—
PEG Ratio
-0.31
P/S (TTM)
0.76
P/B (TTM)
1.28
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-0.55%
ROA (TTM)
-0.25%
ROIC
—
Gross Margin
0.38%
Operating Margin
-0.26%
Net Margin
—
Debt/Equity
0.62
Current Ratio
1.69
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+0.11%
EPS Growth (5Y)
-0.14%
Sales Growth (3Y)
+0.81%
Sales Growth (5Y)
+0.74%
EPS Est (This Year)
$-0.06
EPS Est (Next Year)
$0.28
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$0.12
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
10.65M
Float
8.53M
Free Float %
80.09%
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Country
US
Exchange
NASDAQ
IPO Date
2021-12-22
Employees
19
CEO
Adam R. Levy
Index Membership
—
Website
https://nexgel.com
NEXGEL, Inc. (NXGL) is a healthcare company in the medical - instruments & supplies industry listed on the NASDAQ. With a market capitalization of $8.77M, a P/E ratio of -2.23, NXGL is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare NXGL against other stocks using dozens of fundamental and technical filters.
MHUA
Meihua International Medical Technologies Co., Ltd.
$8.65
+0.23%
$2.74M
POCI
Precision Optics Corporation, Inc.
$4.15
-2.81%
$32.04M
ZJYL
Jin Medical International Ltd.
$2.35
-6.75%
$18.39M
RGNT
Regentis Biomaterials Ltd.
$3.37
+5.88%
$13.26M
CNSL.L
Cambridge Nutritional Sciences plc
$1.90
+0.00%
$4.52M
FEMY
Femasys Inc.
$0.58
-6.22%
$17.08M
NEXGEL, Inc. (NXGL) has a trailing twelve-month (TTM) P/E ratio of -2.23. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, NEXGEL, Inc. (NXGL) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
NEXGEL, Inc. (NXGL) has a market capitalization of $8.77 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.